Kreuter M, Swigris J, Pittrow D, et al. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.

Living with IPF is never dull, says columnist Sam Kirton, who shares some updates on topics he's discussed in recent columns.

I started going to my GP with suspected chest infections and was given a variety of antibiotics over the ... it was IPF – a condition I'd never heard of. My consultant at the time advised ...

A cure for IPF seems closer than ever – but in the notoriously unpredictable world of clinical research, only time will tell which of these approaches, if any, are correct. There’s also ...

Columnist Sam Kirton encourages the IPF community to get a jump on legislative advocacy before the new congressional term begins.

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

A recent study showed that the COPD assessment test was reliable and responsive for assessing health status in fibrotic ...

Referrals to PR and PC for IPF patients in England remain low ... they observed a steady referral proportion increase over time, even among those without a COPD diagnosis. After adjusting for ...

The Association of Real Estate Funds (AREF), the British Property Federation (BPF) and the Investment Property Forum (IPF) ...

The scope of this biotech though is its ability to achieve rapid weight loss in a short amount of time as I ... of patients with idiopathic pulmonary fibrosis. Before going over the advancements ...

Good afternoon, and welcome to the MannKind Corporation third quarter 2024 financial results earnings call. As a reminder, ...

Good afternoon and welcome to the Trevi Therapeutics3rd Quarter, 2024 earnings conference call. At this time, all participants will be in listen-only mode. (Operator Instruction) Please note this ...